Shapiro and UMSOM’s Jeffrey Hasday, MD, honored for discovery of a novel class of drugs that selectively inhibits an enzyme’s role in promoting disease-causing inflammation and has been licensed to GEn1E Lifesciences.

Event enhances collaboration between two Baltimore institutions.

PSC faculty member to oversee growth of the School’s $38.5 million research portfolio.

Novel discovery to help develop therapies for pulmonary, oncology, and muscle degenerative diseases.

Biennial event facilitates scientific exchange and interactive communication among students, postdoctoral fellows, and faculty from two of Baltimore’s premier academic institutions.

Day-long event provides glimpses into potential careers for students and allows alumni to reconnect with faculty and one another.

Graduates and current students in the PhD in Pharmaceutical Sciences and MS in Regulatory Science programs enjoy day-long networking and professional development event.

Event brings together top researchers from two of Baltimore’s premier academic institutions.